AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72

Authors: SAVI P BADORC A LALE A BORDES MF BORNIA J LABOURET C BERNAT A DECOINTET P HOFFMANN P MAFFRAND JP HERBERT JM
Citation: P. Savi et al., SR-121787, A NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST, Thrombosis and haemostasis, 80(3), 1998, pp. 469-476

Authors: MAZELLA J ZSURGER N NAVARRO V CHABRY J KAGHAD M CAPUT D FERRARA P VITA N GULLY D MAFFRAND JP VINCENT JP
Citation: J. Mazella et al., THE 100-KDA NEUROTENSIN RECEPTOR IS GP95 SORTILIN, A NON-G-PROTEIN-COUPLED RECEPTOR/, The Journal of biological chemistry, 273(41), 1998, pp. 26273-26276

Authors: CROCI T OTTOLINA E EMONDSALT X MANARA L LEFUR G MAFFRAND JP
Citation: T. Croci et al., TACHYKININ RECEPTOR ANTAGONISTS PREVENT SENKTIDE, CASTOR-OIL, OR ESCHERICHIA-COLI ENDOTOXIN-INDUCED INCREASE OF FECAL MASS OUTPUT IN GUINEA-PIGS, Gastroenterology, 114(4), 1998, pp. 1475-1475

Authors: BIGNON E BOIGEGRAIN R COTTINEAU M PETEREAU C ROCKSTROH MP SEBAN E SERVANT O PASCAL M MAFFRAND JP LEFUR G
Citation: E. Bignon et al., SR146131 - A NEW, POTENT, NONPEPTIDE ORALLY-ACTIVE CCKA RECEPTOR AGONIST, Gastroenterology, 114(4), 1998, pp. 4621-4621

Authors: PORTIER M COMBES T GULLY D MAFFRAND JP CASELLAS P
Citation: M. Portier et al., NEUROTENSIN TYPE-1 RECEPTOR-MEDIATED ACTIVATION OF KROX24, C-FOS AND ELK-1 - PREVENTING EFFECT OF THE NEUROTENSIN ANTAGONISTS SR-48692 AND SR-142948, FEBS letters, 432(1-2), 1998, pp. 88-93

Authors: VITA N OURYDONAT F CHALON P GUILLEMOT M KAGHAD M BACHY A THURNEYSSEN O GARCIA S POINOTCHAZEL C CASELLAS P KEANE P LEFUR G MAFFRAND JP SOUBRIE P CAPUT D FERRARA P
Citation: N. Vita et al., NEUROTENSIN IS AN ANTAGONIST OF THE HUMAN NEUROTENSIN NT2 RECEPTOR EXPRESSED IN CHINESE-HAMSTER OVARY CELLS, European journal of pharmacology, 360(2-3), 1998, pp. 265-272

Authors: CROCI T AUREGGI G MANARA L EMONDSALT X LEFUR G MAFFRAND JP MUKENGE S FERLA G
Citation: T. Croci et al., IN-VITRO CHARACTERIZATION OF TACHYKININ NK2-RECEPTORS MODULATING MOTOR-RESPONSES OF HUMAN COLONIC MUSCLE STRIPS, British Journal of Pharmacology, 124(6), 1998, pp. 1321-1327

Authors: LABIE C LAFON C FOURNIER J KEANE PE LEFUR G MAFFRAND JP SOUBRIE P
Citation: C. Labie et al., EFFECT OF THE NONPEPTIDE NEUROPROTECTIVE COMPOUND SR57746A ON NGF ANDBDNF SYNTHESIS IN PRIMARY ASTROCYTES IN CULTURE, British Journal of Pharmacology, 123, 1998, pp. 80-80

Authors: LECOMPTE TP LECRUBIER C BOULOUX C HORELLOU MH GALLEYRAND J MAFFRAND JP SAMAMA MM
Citation: Tp. Lecompte et al., ANTIPLATELET EFFECTS OF THE ADDITION OF ACETYLSALICYLIC-ACID 40 MG DAILY TO TICLOPIDINE IN HUMAN HEALTHY-VOLUNTEERS, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 245-250

Authors: SAVI P BADORC A LALE A MAFFRAND JP BERNAT A HOFFMANN P HERBERT JM
Citation: P. Savi et al., SR-121787 - A POTENT, SYNTHETIC AND ORALLY-ACTIVE PLATELET FIBRINOGENRECEPTOR ANTAGONIST, Thrombosis and haemostasis, 1997, pp. 1599-1599

Authors: EMONDSALT X ADVENIER C COGNON C CROCI T DAOUI S DUCOUX JP LANDI M NALINE E NELIAT G PONCELET M PROLETTO V VANBROECK D VILAIN P SOUBRIE P LEFUR G MAFFRAND JP BRELIERE JC
Citation: X. Emondsalt et al., BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITIES OF SR-144190, A NEW POTENTNONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST, Neuropeptides, 31(5), 1997, pp. 449-458

Authors: GULLY D LABEEUW B BOIGEGRAIN R OURYDONAT F BACHY A PONCELET M STEINBERG R SUAUDCHAGNY MF SANTUCCI V VITA N PECCEU F LABBEJULLIE C KITABGI P SOUBRIE P LEFUR G MAFFRAND JP
Citation: D. Gully et al., BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITIES OF SR 142948A, A NEW POTENT NEUROTENSIN RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 280(2), 1997, pp. 802-812

Authors: BADORC A BORDES MF DECOINTET P SAVI P BERNAT A LALE A PETITOU M MAFFRAND JP HERBERT JM
Citation: A. Badorc et al., NEW ORALLY-ACTIVE NONPEPTIDE FIBRINOGEN RECEPTOR (GPIIB-IIIA) ANTAGONISTS - IDENTIFICATION OF ETHYL THOXYCARBONYL)METHYL]PIPERID-4-YL]AMINO]PROPIONATE (SR-121787) AS A POTENT AND LONG-ACTING ANTITHROMBOTIC AGENT, Journal of medicinal chemistry, 40(21), 1997, pp. 3393-3401

Authors: JBILO O VIDAL H PAUL R DENYS N BENSAID M SILVE S CARAYON P DAVI D GALIEGUE S BOURRIE B GUILLEMOT JC FERRARA P LOISON G MAFFRAND JP LEFUR G CASELLAS P
Citation: O. Jbilo et al., PURIFICATION AND CHARACTERIZATION OF THE HUMAN SR 31747A-BINDING PROTEIN - A NUCLEAR-MEMBRANE PROTEIN RELATED TO YEAST STEROL ISOMERASE, The Journal of biological chemistry, 272(43), 1997, pp. 27107-27115

Authors: BOUABOULA M PERRACHON S MILLIGAN L CANAT X RINALDICARMONA M PORTIER M BARTH F CALANDRA B PECCEU F LUPKER J MAFFRAND JP LEFUR G CASELLAS P
Citation: M. Bouaboula et al., A SELECTIVE INVERSE AGONIST FOR CENTRAL CANNABINOID RECEPTOR INHIBITSMITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION STIMULATED BY INSULIN OR INSULIN-LIKE-GROWTH-FACTOR-1 - EVIDENCE FOR A NEW MODEL OF RECEPTOR LIGAND INTERACTIONS/, The Journal of biological chemistry, 272(35), 1997, pp. 22330-22339

Authors: CROCI T OTTOLINA E GULLY D MAFFRAND JP LEFUR G MANARA L
Citation: T. Croci et al., THE NEUROTENSIN RECEPTOR ANTAGONIST SR-48692 PROMOTES GASTRIC-EMPTYING IN DAHL-S BUT NOT SH HYPERTENSIVE RATS, Gastroenterology, 112(4), 1997, pp. 356-356

Authors: CROCI T AUREGGI G MANARA L EMONDSALT X GULLY D MAFFRAND JP LEFUR G MUKENGE S FERLA G
Citation: T. Croci et al., FUNCTIONAL NEUROTENSIN AND TACHYKININ NK2-RECEPTORS IN HUMAN COLON STRIPS, Gastroenterology, 112(4), 1997, pp. 716-716

Authors: LEGAL CS RAUFASTE D BROSSARD G POUZET B MARTY E MAFFRAND JP LEFUR G
Citation: Cs. Legal et al., CHARACTERIZATION AND LOCALIZATION OF LEPTIN RECEPTORS IN THE RAT-KIDNEY, FEBS letters, 404(2-3), 1997, pp. 185-191

Authors: CROCI T MANARA L AUREGGI G GUAGNINI F MAFFRAND JP LEFUR G MUKENGE S FERLA G
Citation: T. Croci et al., QUANTITATIVE ANTAGONISM (PA(2)) BY PROPRANOLOL AND CGP 12177A OF ISOPRENALINE RELAXATION OF THE ISOLATED HUMAN COLON PROVIDES FUNCTIONAL EVIDENCE OF BETA(3)-ADRENOCEPTORS, British Journal of Pharmacology, 122, 1997, pp. 139-139

Authors: CASELLAS P BOUABOULA M PERRACHON S MILLIGAN L CANAT X RINALDICARMONA M PORTIER M PECCEU F MAFFRAND JP LEFUR G
Citation: P. Casellas et al., A SELECTIVE INVERSE AGONIST FOR CENTRAL CANNABINOID RECEPTOR INHIBITSMAPK ACTIVATION STIMULATED BY INSULIN OR IGF1, British Journal of Pharmacology, 122, 1997, pp. 215-215

Authors: CROCI T LANDI M EMONDSALT X LEFUR G MAFFRAND JP MANARA L
Citation: T. Croci et al., ROLE OF TACHYKININS IN CASTOR-OIL DIARRHEA IN RATS, British Journal of Pharmacology, 121(3), 1997, pp. 375-380

Authors: CROCI T LANDI M GULLY D MAFFRAND JP LEFUR G MANARA L
Citation: T. Croci et al., NEGATIVE MODULATION OF NITRIC-OXIDE PRODUCTION BY NEUROTENSIN AS A PUTATIVE MECHANISM OF THE DIURETIC ACTION OF SR-48692 IN RATS, British Journal of Pharmacology, 120(7), 1997, pp. 1312-1318

Authors: FERRY S CHATEL B DODD RH LAIR C GULLY D MAFFRAND JP RUAT M
Citation: S. Ferry et al., EFFECTS OF DIVALENT-CATIONS AND OF A CALCIMIMETIC ON ADRENOCORTICOTROPIC HORMONE-RELEASE IN PITUITARY-TUMOR CELLS, Biochemical and biophysical research communications, 238(3), 1997, pp. 866-873

Authors: ZAJAC JM GULLY D MAFFRAND JP
Citation: Jm. Zajac et al., [H-3] SR27897B - A SELECTIVE PROBE FOR AUTORADIOGRAPHIC LABELING OF CCK-A RECEPTORS IN THE BRAIN, Journal of receptor and signal transduction research, 16(1-2), 1996, pp. 93-113

Authors: CROCI T LANDI M GULLY D MAFFRAND JP LEFUR G MANARA L
Citation: T. Croci et al., NEGATIVE MODULATION OF NITRIC-OXIDE PRODUCTION BY NEUROTENSIN AS A PUTATIVE MECHANISM OF THE DIURETIC ACTION OF ITS SPECIFIC ANTAGONIST, SR-48692, IN RATS, The FASEB journal, 10(3), 1996, pp. 2536-2536
Risultati: 1-25 | 26-50 | 51-72